ReviewArthroscopy, sports medicine, and rehabilitation2025
Patients Who Underwent Anterior Cruciate Ligament Reconstruction With an All Soft-Tissue Quadriceps Tendon Graft Had a Greater Return-to-Play Rate Than Patients Who Received a Quadriceps Tendon Bone Graft.
Review in Arthroscopy, sports medicine, and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the outcomes after anterior cruciate ligament reconstruction (ACLR) with either a quadriceps tendon bone (QTB) graft or an all soft-tissue quadriceps tendon (ASTQT) graft and to compare QTB versus ASTQT graft options, including return to play, patient-reported outcome scores, and complication rates. Methods: A systematic review was conducted by searching PubMed, Embase, SCOPUS, and Cochrane databases for studies published between 2003 and 2023, focusing on outcomes of quadriceps tendon autograft in ACLR. Results: In total, 37 studies with a total of 39 cohorts (n = 2,647) met inclusion criteria. The studies included 22 cohorts (n = 1,825 patients) for QTB and 17 cohorts (n = 822 patients) for ASTQT. Patients who underwent ACLR with ASTQT graft had a greater rate of return to play compared with those with a QTB (84% to 90% vs 45%-85%). Between ASTQT and QTB graft constructs, International Knee Documentation Committee scores (77.4 to 94.8 vs 71.2 to 92), Lysholm scores (85-95.5 vs 86-96.1), Knee injury and Osteoarthritis Outcome Score-Pain (88.9-89.7 vs 90-90.7), return-to-play times (269.2-319.4 days vs 337.6 days), and revision rates (2.3%-12.8% vs 0%-2.9%) were similar. Conclusions: Our analysis shows a greater return-to-play rate in patients who underwent ACLR with an ASTQT compared with QTB graft. No differences were found in patient-reported outcome scores or revision rates. Level of Evidence: Level IV, systematic review of Level I-IV studies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.